Trials / Unknown
UnknownNCT04945954
Pharmacokinetic Study of Post-transplant Cyclophosphamide in Pediatric Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an investigator-initiated clinical trial to analysis population pharmacokinetic characteristics and investigate appropriate pediatric dose of Cyclophosphamide in pediatric hematopoietic stem cell transplantation patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Drug: Cyclophosphamide | Administer 14.5mg/kg of Cyclophosphamide once a day for 4days. (intravenously) Blood sampling of pharmacokinetics(PK) of cyclophosphamide will be performed in all patients who have taken the investigational drug for at least 4 days (For 2 days, It will be administered for pretreatment of transplant, for the other 2 days, It will be administered for Post-transplant treatment for the prevention of GVHD) |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2021-06-30
- Last updated
- 2021-06-30
Source: ClinicalTrials.gov record NCT04945954. Inclusion in this directory is not an endorsement.